×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
GILD – gilead sciences, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
GILD
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/3
10:26 pm
gild
Gilead (GILD) Valuation After Fresh Buy Rating and Extended Biktarvy Exclusivity Boost Investor Confidence [Yahoo! Finance]
Low
Report
Gilead (GILD) Valuation After Fresh Buy Rating and Extended Biktarvy Exclusivity Boost Investor Confidence [Yahoo! Finance]
12/2
06:44 am
gild
Madonna pens scathing post against Trump for 'unthinkable' decision to ignore World AIDS Day [FOX News]
Low
Report
Madonna pens scathing post against Trump for 'unthinkable' decision to ignore World AIDS Day [FOX News]
12/1
06:33 pm
gild
Mableton man uses TikTok to fight HIV stigma as federal government skips World AIDS Day recognition [CBS News]
Low
Report
Mableton man uses TikTok to fight HIV stigma as federal government skips World AIDS Day recognition [CBS News]
12/1
05:29 pm
gild
Elton John reveals what would make Trump one of the 'greatest presidents' in history [FOX News]
Low
Report
Elton John reveals what would make Trump one of the 'greatest presidents' in history [FOX News]
12/1
04:37 pm
gild
National AIDS Memorial Marks World AIDS Day with Two Signature Events Highlighting the Power of Communities to Shape Progress in the Fight Against HIV/AIDS and Advance Health and Social Justice [Yahoo! Finance]
Low
Report
National AIDS Memorial Marks World AIDS Day with Two Signature Events Highlighting the Power of Communities to Shape Progress in the Fight Against HIV/AIDS and Advance Health and Social Justice [Yahoo! Finance]
12/1
09:10 am
gild
Trump's global health strategy could mark a turning point in the AIDS battle [FOX News]
Low
Report
Trump's global health strategy could mark a turning point in the AIDS battle [FOX News]
12/1
08:46 am
gild
Groundbreaking HIV Prevention Shots Begin In Africa [Barron's]
Low
Report
Groundbreaking HIV Prevention Shots Begin In Africa [Barron's]
12/1
08:12 am
gild
An unsuspecting group of women are getting HIV. Geography is in part to blame. [USA TODAY]
Low
Report
An unsuspecting group of women are getting HIV. Geography is in part to blame. [USA TODAY]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/1
06:12 pm
gild
Form 4 GILEAD SCIENCES, INC. For: Nov 28 Filed by: Bluestone Jeffrey
Low
Report
Form 4 GILEAD SCIENCES, INC. For: Nov 28 Filed by: Bluestone Jeffrey
12/1
04:55 pm
gild
Form 4 GILEAD SCIENCES, INC. For: Nov 26 Filed by: Kramer Kelly A.
Medium
Report
Form 4 GILEAD SCIENCES, INC. For: Nov 26 Filed by: Kramer Kelly A.
12/1
04:51 pm
gild
Form 4 GILEAD SCIENCES, INC. For: Nov 28 Filed by: O'Day Daniel Patrick
Low
Report
Form 4 GILEAD SCIENCES, INC. For: Nov 28 Filed by: O'Day Daniel Patrick
11/28
01:06 pm
gild
Form 144 GILEAD SCIENCES, INC. Filed by: O'Day Daniel Patrick
Neutral
Report
Form 144 GILEAD SCIENCES, INC. Filed by: O'Day Daniel Patrick
11/28
01:03 pm
gild
Form 144 GILEAD SCIENCES, INC. Filed by: Bluestone Jeffrey
Neutral
Report
Form 144 GILEAD SCIENCES, INC. Filed by: Bluestone Jeffrey
11/26
04:16 pm
gild
Form 144 GILEAD SCIENCES, INC. Filed by: Kramer Kelly A.
Low
Report
Form 144 GILEAD SCIENCES, INC. Filed by: Kramer Kelly A.
11/19
08:30 am
gild
Form 8-K GILEAD SCIENCES, INC. For: Nov 15
Low
Report
Form 8-K GILEAD SCIENCES, INC. For: Nov 15
11/18
07:00 pm
gild
Form 4 GILEAD SCIENCES, INC. For: Nov 17 Filed by: Dickinson Andrew D
Low
Report
Form 4 GILEAD SCIENCES, INC. For: Nov 17 Filed by: Dickinson Andrew D
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/18
Japanese flu drug appears ‘effective’ in coronavirus treatment in Chinese clinical trials [TechCrunch Blog]
9.5%
3/1 2 Stocks That Can Help You Protect Your Wealth From a Coronavirus Pandemic [The Motley Fool] 8.3%
2/25 U.S. Health Officials Start First Clinical Trial With Gilead Sciences' Experimental Coronavirus Treatment [The Motley Fool] 6.6%
3/6 Can Gilead Change Its Dim Fortunes On An Immuno-Oncology Buyout? [Investor's Business Daily] 6.4%
4/2 Gilead in-licenses multiple CAR antibodies from TeneoBio [Seeking Alpha] 6.2%
4/29 Gilead's remdesivir meets main goal of trial in COVID-19 patients [Reuters] 5.5%
1/31 UPDATE 2-Gilead working with China to test Ebola drug as new coronavirus treatment [Reuters] 5.0%
3/10 Gilead Presents 96-week DISCOVER Trial Data Demonstrating Favorable Renal and Bone Safety Profile of Descovy® for HIV PrEP in At-Risk Populations 4.7%
3/26 Gilead Sciences, Inc. (NASDAQ: GILD) had its "buy" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $83.00 price target on the stock. 4.5%
4/24 European shares slide as EU stimulus fails to impress [Reuters] 3.8%
3/1 2 Stocks That Can Help You Protect Your Wealth From a Coronavirus Pandemic [The Motley Fool] 8.3%
2/25 U.S. Health Officials Start First Clinical Trial With Gilead Sciences' Experimental Coronavirus Treatment [The Motley Fool] 6.6%
3/6 Can Gilead Change Its Dim Fortunes On An Immuno-Oncology Buyout? [Investor's Business Daily] 6.4%
4/2 Gilead in-licenses multiple CAR antibodies from TeneoBio [Seeking Alpha] 6.2%
4/29 Gilead's remdesivir meets main goal of trial in COVID-19 patients [Reuters] 5.5%
1/31 UPDATE 2-Gilead working with China to test Ebola drug as new coronavirus treatment [Reuters] 5.0%
3/10 Gilead Presents 96-week DISCOVER Trial Data Demonstrating Favorable Renal and Bone Safety Profile of Descovy® for HIV PrEP in At-Risk Populations 4.7%
3/26 Gilead Sciences, Inc. (NASDAQ: GILD) had its "buy" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $83.00 price target on the stock. 4.5%
4/24 European shares slide as EU stimulus fails to impress [Reuters] 3.8%
TOP News Decliners
3/20
Gilead Sciences, Inc. (NASDAQ: GILD) was upgraded by analysts at Piper Sandler from a "neutral" rating to an "overweight" rating. They now have a $90.00 price target on the stock, up previously from $70.00.
-9.3%
2/27 Gilead Sciences, Inc. (NASDAQ: GILD) is now covered by analysts at Barclays PLC. They set an "underweight" rating on the stock. -9.1%
3/6 Gilead Surges To 2-Year High On Expectations For Speedy Coronavirus Drug [Investor's Business Daily] -8.4%
2/3 Gilead +12% on coronavirus treatment testing [Seeking Alpha] -7.3%
3/11 The index dropped at least 20% from its recent peak as coronavirus continues to whiplash investors [CNN] -6.6%
2/25 U.S. Stock-Index Futures Advance on Dip-Buying After Rout [Yahoo! Finance News] -6.4%
2/27 Gilead Sciences makes takeover approach to Forty Seven: Bloomberg News [Reuters] -6.3%
4/16 Gilead surges after report suggests COVID-19 patients responding to remdesivir [Reuters] -5.8%
3/24 Form DEF 14A GILEAD SCIENCES INC For: May 06 -5.6%
4/20 Dow futures fall more than 150 points as US crude prices plunge [CNBC] -5.0%
2/27 Gilead Sciences, Inc. (NASDAQ: GILD) is now covered by analysts at Barclays PLC. They set an "underweight" rating on the stock. -9.1%
3/6 Gilead Surges To 2-Year High On Expectations For Speedy Coronavirus Drug [Investor's Business Daily] -8.4%
2/3 Gilead +12% on coronavirus treatment testing [Seeking Alpha] -7.3%
3/11 The index dropped at least 20% from its recent peak as coronavirus continues to whiplash investors [CNN] -6.6%
2/25 U.S. Stock-Index Futures Advance on Dip-Buying After Rout [Yahoo! Finance News] -6.4%
2/27 Gilead Sciences makes takeover approach to Forty Seven: Bloomberg News [Reuters] -6.3%
4/16 Gilead surges after report suggests COVID-19 patients responding to remdesivir [Reuters] -5.8%
3/24 Form DEF 14A GILEAD SCIENCES INC For: May 06 -5.6%
4/20 Dow futures fall more than 150 points as US crude prices plunge [CNBC] -5.0%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: